In this study, we tested the hypothesis that the response to neoadjuvant/perioperative chemotherapy correlates with the expression of four different CSC markers of GC, i.e., LGR5, FZD7, TROY, and MIST1 by using clinical samples. The gene discussed is LGR5; the disease is gastric cancer.